Cargando…

Carbogen and nicotinamide in the treatment of bladder cancer with radical radiotherapy.

Carbogen and nicotinamide have been evaluated in a phase II study as hypoxia-modifying agents during radical radiotherapy for bladder cancer using a standard daily 20-fraction schedule. Three groups of patients have received (a) nicotinamide alone, given orally in a dose of 80 mg kg(-1) daily with 5...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoskin, P. J., Saunders, M. I., Phillips, H., Cladd, H., Powell, M. E., Goodchild, K., Stratford, M. R., Rojas, A.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1997
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2223941/ https://www.ncbi.nlm.nih.gov/pubmed/9231929

Ejemplares similares

Pharmacokinetics of varying doses of nicotinamide and tumour radiosensitisation with carbogen and nicotinamide: clinical considerations.
por: Rojas, A., et al.
Publicado: (1993)

Carbogen breathing with nicotinamide improves the oxygen status of tumours in patients.
por: Laurence, V. M., et al.
Publicado: (1995)

The effects of carbogen and nicotinamide on intravascular oxyhaemoglobin saturations in SCCVII and KHT murine tumours.
por: Fenton, B. M.
Publicado: (1995)

Effects of nicotinamide and carbogen on tumour oxygenation, blood flow, energetics and blood glucose levels
por: Robinson, S P, et al.
Publicado: (2000)

Perfusion changes in the RIF-1 tumour and normal tissues after carbogen and nicotinamide, individually and combined.
por: Honess, D. J., et al.
Publicado: (1995)

Experience with dose escalation using CHARTWEL (continuous hyperfractionated accelerated radiotherapy weekend less) in non-small-cell lung cancer.
por: Saunders, M. I., et al.
Publicado: (1998)

Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivo.
por: Chaplin, D. J., et al.
Publicado: (1991)

Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
por: Chaplin, D. J., et al.
Publicado: (1993)

Nicotinamide pharmacokinetics in humans: effect of gastric acid inhibition, comparison of rectal vs oral administration and the use of saliva for drug monitoring.
por: Stratford, M. R., et al.
Publicado: (1996)

Carbogen breathing increases prostate cancer oxygenation: a translational MRI study in murine xenografts and humans
por: Alonzi, R, et al.
Publicado: (2009)

PB2134: THE ROLE OF ADDITIONAL CARBOGEN GAS MIXTURE AND NICOTINAMIDE ON R-CHOP CHEMOTHERAPY IN DLBCL PATIENTS WITH TUMOR HYPOXIA
por: Rizky, D., et al.
Publicado: (2022)

Paving the path to the future of carbogenic nanodots
por: Verma, Navneet C., et al.
Publicado: (2019)

The effects of carbogen and hyperbaric oxygen treatment on fracture healing in rats
por: Menendi, Umman, et al.
Publicado: (2022)

The mechanisms by which hyperbaric oxygen and carbogen improve tumour oxygenation.
por: Brizel, D. M., et al.
Publicado: (1995)

Temporal variation in the response of tumors to hyperoxia with breathing carbogen and oxygen
por: Hou, Hua-gang, et al.
Publicado: (2016)

Carbogen-induced changes in rat mammary tumour oxygenation reported by near infrared spectroscopy
por: Hull, E L, et al.
Publicado: (1999)

A randomized prospective study of extended tocopherol and pentoxifylline therapy, in addition to carbogen, in the treatment of radiation late effects
por: Brennan, S, et al.
Publicado: (2008)

The impact of bladder preparation protocols on post treatment toxicity in radiotherapy for localised prostate cancer patients
por: Tsang, Yat Man, et al.
Publicado: (2017)

Perfluorocarbon nanodroplets can reoxygenate hypoxic tumors in vivo without carbogen breathing
por: Xiang, Yun, et al.
Publicado: (2019)

The influence of carbogen breathing on tumour tissue oxygenation in man evaluated by computerised p02 histography.
por: Falk, S. J., et al.
Publicado: (1992)

Perfluorocarbon emulsions radiosensitise brain tumors in carbogen breathing mice with orthotopic GL261 gliomas
por: Feldman, Lisa A., et al.
Publicado: (2017)

The response to carbogen breathing in experimental tumour models monitored by gradient-recalled echo magnetic resonance imaging.
por: Robinson, S. P., et al.
Publicado: (1997)

Therapeutic Effects of Carbogen Inhalation and Lipo-Prostaglandin E1 in Sudden Hearing Loss
por: Lee, Hyun-Jin, et al.
Publicado: (2012)

Carbogenic nanodots derived from organo-templated zeolites with modulated full-color luminescence
por: Mu, Ying, et al.
Publicado: (2016)

A practical approach to bladder preservation with hypofractionated radiotherapy for localised muscle-invasive bladder cancer
por: Portner, R., et al.
Publicado: (2021)

The Effect of Carbogen Breathing on (18)F-FDG Uptake in Non-Small-Cell Lung Cancer
por: Lin, Yu, et al.
Publicado: (2019)

A drug for improved radiosensitization in radiotherapy.
por: Dische, S., et al.
Publicado: (1980)

The effects of host carbogen (95% oxygen/5% carbon dioxide) breathing on metabolic characteristics of Morris hepatoma 9618a.
por: Stubbs, M., et al.
Publicado: (1998)

Effectiveness of postoperative radiotherapy after radical cystectomy for locally advanced bladder cancer
por: Fischer‐Valuck, Benjamin W., et al.
Publicado: (2019)

RSR13, an allosteric effector of haemoglobin, and carbogen radiosensitize FSAII and SCCVII tumours in C3H mice
por: Khandelwal, S R, et al.
Publicado: (1999)

Carbogen gas-challenge BOLD fMRI in assessment of liver hypoxia after portal microcapsules implantation
por: Zhan, Yuefu, et al.
Publicado: (2019)

Carbogen inhalation during non-convulsive status epilepticus: A quantitative exploratory analysis of EEG recordings
por: Ramaraju, S., et al.
Publicado: (2021)

Radical External-Beam Radiotherapy in Combination With Intracavitary Brachytherapy for Localized Carcinoma of the Cervix in Sri Lanka: Is Treatment Delayed Treatment Denied?
por: Joseph, Nuradh, et al.
Publicado: (2020)

Carbogen gas-challenge blood oxygen level-dependent magnetic resonance imaging in hepatocellular carcinoma: Initial results
por: ZHANG, LONG JIANG, et al.
Publicado: (2015)

In vivo detection of ifosfamide by 31P-MRS in rat tumours: increased uptake and cytotoxicity induced by carbogen breathing in GH3 prolactinomas.
por: Rodrigues, L. M., et al.
Publicado: (1997)

Prognostic value of serum nicotinamide phosphoribosyltransferase in patients with bladder cancer
por: Zhang, Kui, et al.
Publicado: (2014)

Persistent correction of hyperglycemia in streptozotocin-nicotinamide-induced diabetic mice by a non-conventional radical scavenger
por: Novelli, M., et al.
Publicado: (2010)

Bladder neck necrosis resulting in fistulae to rectum and bilateral thighs post radical prostatectomy and salvage radiotherapy
por: Southall, Thomas M., et al.
Publicado: (2021)

Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance
por: Hafeez, Shaista, et al.
Publicado: (2020)

Pattern of Failure in Bladder Cancer Patients Treated with Radical Cystectomy: Rationale for Adjuvant Radiotherapy
por: Kim, Yong Bae, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_tb91d2ijsj858a72h87v5ttk7n